<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Sun, 24 May 2026 19:45:40 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/conjugates/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Antibody Drug Conjugates Market Analysis and Research 2018]]></title><description><![CDATA[Antibody Drug Conjugates are the fastest growing class of oncology therapeutics. These are monoclonal antibody based therapies which have achieved great success in the field of cancer treatment, primarily]]></description><link>http://direct.ecency.com/antibody/@nayara-rajput/antibody-drug-conjugates-market-analysis-and-research-2018</link><guid isPermaLink="true">http://direct.ecency.com/antibody/@nayara-rajput/antibody-drug-conjugates-market-analysis-and-research-2018</guid><category><![CDATA[antibody]]></category><dc:creator><![CDATA[nayara-rajput]]></dc:creator><pubDate>Wed, 28 Feb 2018 10:32:30 GMT</pubDate></item></channel></rss>